Valuation (14%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -2.04 | 44.44 |
PEG Ratio (TTM) | 1.76 | 0.61 |
P/S Ratio (TTM) | 2.93 | 18.49 |
P/B Ratio (TTM) | -1.00 | 14.63 |
P/FCF Ratio (TTM) | -3.82 | 39.14 |
Price to 5YR AVG Earnings Ratio | 0.00 | 62.70 |
Price to 5YR AVG FCF Ratio | 0.00 | 89.41 |
Profitability (25%) |
Company | Industry |
---|---|---|
ROA (TTM) | -40.37% | -3.01% |
ROE (TTM) | -504.59% | 8.64% |
Net Profit Margin (TTM) | -143.32% | 3.79% |
ROIC 5YR AVG | 111.49% | 4.88% |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -253.82% | -863,292.72% | -518,069.58% |
Revenue | 77.40% | 24.33% | 42.75% |
Net Income | -1,458.18% | -787,825.51% | -472,793.78% |
Cash Flow | -6.07% | -826,050.45% | -495,634.08% |
Health (35%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 5.52 | 1.82 |
Quick Ratio (TTM) | 5.41 | 1.81 |
D/E Ratio (TTM) | N/A | 0.51 |
Interest Coverage (TTM) | N/A | 12.56 |
Piotroski F-Score | 4 | 6 |
Altman Z-Score | N/A | 10.25 |
LTL to 5YR AVG FCF | -0.26 | 3.69 |
Shares Outstanding Growth 5YR AVG | 67.52% | 42.91% |